213 related articles for article (PubMed ID: 34175815)
1. New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities.
Ashrafizadeh M; Mirzaei S; Hashemi F; Zarrabi A; Zabolian A; Saleki H; Sharifzadeh SO; Soleymani L; Daneshi S; Hushmandi K; Khan H; Kumar AP; Aref AR; Samarghandian S
Biomed Pharmacother; 2021 Sep; 141():111824. PubMed ID: 34175815
[TBL] [Abstract][Full Text] [Related]
2. Zinc promotes prostate cancer cell chemosensitivity to paclitaxel by inhibiting epithelial-mesenchymal transition and inducing apoptosis.
Xue YN; Yu BB; Liu YN; Guo R; Li JL; Zhang LC; Su J; Sun LK; Li Y
Prostate; 2019 May; 79(6):647-656. PubMed ID: 30714183
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of paclitaxel resistance via PI3K‑dependent epithelial‑mesenchymal transition in A2780 human ovarian cancer cells.
Du F; Wu X; Liu Y; Wang T; Qi X; Mao Y; Jiang L; Zhu Y; Chen Y; Zhu R; Han X; Jin J; Ma X; Hua D
Oncol Rep; 2013 Sep; 30(3):1113-8. PubMed ID: 23807572
[TBL] [Abstract][Full Text] [Related]
5. Multi-CpG linear regression models to accurately predict paclitaxel and docetaxel activity in cancer cell lines.
Bacolod MD; Fisher PB; Barany F
Adv Cancer Res; 2023; 158():233-292. PubMed ID: 36990534
[TBL] [Abstract][Full Text] [Related]
6. Histone demethylase KDM5A enhances cell proliferation, induces EMT in lung adenocarcinoma cells, and have a strong causal association with paclitaxel resistance.
Xu L; Wu H; Hu X
Acta Biochim Pol; 2021 Jul; 68(4):593-602. PubMed ID: 34270886
[TBL] [Abstract][Full Text] [Related]
7. MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel in vitro and in vivo.
Sampath D; Discafani CM; Loganzo F; Beyer C; Liu H; Tan X; Musto S; Annable T; Gallagher P; Rios C; Greenberger LM
Mol Cancer Ther; 2003 Sep; 2(9):873-84. PubMed ID: 14555706
[TBL] [Abstract][Full Text] [Related]
8. Activity of docetaxel in paclitaxel-resistant ovarian cancer cells.
Sato S; Kigawa J; Kanamori Y; Itamochi H; Oishi T; Shimada M; Iba T; Naniwa J; Uegaki K; Terakawa N
Cancer Chemother Pharmacol; 2004 Mar; 53(3):247-52. PubMed ID: 14610615
[TBL] [Abstract][Full Text] [Related]
9. Chitosan-based advanced materials for docetaxel and paclitaxel delivery: Recent advances and future directions in cancer theranostics.
Ashrafizadeh M; Ahmadi Z; Mohamadi N; Zarrabi A; Abasi S; Dehghannoudeh G; Tamaddondoust RN; Khanbabaei H; Mohammadinejad R; Thakur VK
Int J Biol Macromol; 2020 Feb; 145():282-300. PubMed ID: 31870872
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc.
Chen D; Huang J; Zhang K; Pan B; Chen J; De W; Wang R; Chen L
Eur J Cancer; 2014 Nov; 50(17):3050-67. PubMed ID: 25310895
[TBL] [Abstract][Full Text] [Related]
12. SMAD3 inducing the transcription of STYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel.
Shi Y; Zhang J; Liu M; Huang Y; Yin L
J Cell Biochem; 2019 Jun; 120(6):10796-10811. PubMed ID: 30701575
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line.
Ren J; Chen Y; Song H; Chen L; Wang R
J Cell Biochem; 2013 Jun; 114(6):1395-403. PubMed ID: 23255418
[TBL] [Abstract][Full Text] [Related]
14. A miRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial-mesenchymal transition.
Zhao YF; Han ML; Xiong YJ; Wang L; Fei Y; Shen X; Zhu Y; Liang ZQ
Acta Pharmacol Sin; 2018 Jun; 39(6):1034-1047. PubMed ID: 29219949
[TBL] [Abstract][Full Text] [Related]
15. The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.
Hanrahan K; O'Neill A; Prencipe M; Bugler J; Murphy L; Fabre A; Puhr M; Culig Z; Murphy K; Watson RW
Mol Oncol; 2017 Mar; 11(3):251-265. PubMed ID: 28133913
[TBL] [Abstract][Full Text] [Related]
16. Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition.
Duran GE; Wang YC; Moisan F; Francisco EB; Sikic BI
Br J Cancer; 2017 May; 116(10):1318-1328. PubMed ID: 28399108
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety Assessment of Paclitaxel in Patients with Docetaxel-Resistant Esophageal Squamous Cell Carcinoma.
Imai H; Komine K; Takahashi S; Saijo K; Okada Y; Kobayashi A; Okita A; Chikamatsu S; Kasahara Y; Takahashi M; Oishi T; Shirota H; Takahashi M; Shimodaira H; Ishioka C
Chemotherapy; 2016; 61(5):262-8. PubMed ID: 27043795
[TBL] [Abstract][Full Text] [Related]
18. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.
Kajiyama H; Shibata K; Terauchi M; Yamashita M; Ino K; Nawa A; Kikkawa F
Int J Oncol; 2007 Aug; 31(2):277-83. PubMed ID: 17611683
[TBL] [Abstract][Full Text] [Related]
19. BGJ398, A Pan-FGFR Inhibitor, Overcomes Paclitaxel Resistance in Urothelial Carcinoma with FGFR1 Overexpression.
Kim SH; Ryu H; Ock CY; Suh KJ; Lee JY; Kim JW; Lee JO; Kim JW; Kim YJ; Lee KW; Bang SM; Kim JH; Lee JS; Ahn JB; Kim KJ; Rha SY
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30326563
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid reverses epithelial-mesenchymal transition in paclitaxel-resistant cells by inhibiting nuclear factor kappa B and upregulating gap junctions.
Shi G; Zheng X; Wu X; Wang S; Wang Y; Xing F
Cancer Sci; 2019 Jan; 110(1):379-388. PubMed ID: 30375704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]